YOUNG WILLIAM D
SEC insider (Form 3/4/5 filer). CIK 0001217420. Director at Autolus Therapeutics plc (AUTL) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in LONDON.
Companies YOUNG WILLIAM D has filed insider reports for
- Autolus Therapeutics plc (AUTL): Director
- Praxis Precision Medicines, Inc. (PRAX): Director
YOUNG WILLIAM D
CIK: 0001217420
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectRestricted Share Units
31.7K shares- - Jun 29, 2026AUTL
Autolus Therapeutics plc
AwardDirectShare Option (Right to Buy)
47.5K shares- - Jun 10, 2026PRAX
Praxis Precision Medicines, Inc.
AwardDirect1.4K shares- - Jun 26, 2025PRAX
Praxis Precision Medicines, Inc.
AwardDirectStock Option (Right to Buy)
10.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 |  AUTL Autolus Therapeutics plc | Award Restricted Share Units | 31,667 | - | - | Direct |
| Jun 29, 2026 | AUTL Autolus Therapeutics plc | Award Share Option (Right to Buy) | 47,500 | - | - | Direct |
| Jun 10, 2026 |  PRAX Praxis Precision Medicines, Inc. | Award | 1,371 | - | $0 | Direct |
| Jun 26, 2025 | PRAX Praxis Precision Medicines, Inc. | Award Stock Option (Right to Buy) | 10,520 | - | - | Direct |
1-4 of 4 transactions